Roche receives positive CHMP opinion for Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer
Basel, 18 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma (HCC) who have not received prior systemi c therapy. Based on this recommendation, a final decision regarding approval of Tecentriq in combination with Avastin in this disease setting, along with the full details of the approved indication, is expe...
Source: Roche Media News - September 18, 2020 Category: Pharmaceuticals Source Type: news

Roche receives positive CHMP opinion for Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer
Basel, 18 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma (HCC) who have not received prior systemi c therapy. Based on this recommendation, a final decision regarding approval of Tecentriq in combination with Avastin in this disease setting, along with the full details of the approved indication, is expe...
Source: Roche Investor Update - September 18, 2020 Category: Pharmaceuticals Source Type: news

HCV-Related Liver Cancer Incidence Dropped in US Cohort HCV-Related Liver Cancer Incidence Dropped in US Cohort
The incidence of hepatocellular carcinoma declined after widespread use of direct-acting antiviral therapies to treat hepatitis C, according to findings from a large population-based study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 16, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Extrahepatic Cancers Among Persons With Chronic HBV or HBC Extrahepatic Cancers Among Persons With Chronic HBV or HBC
Is chronic HBV or HCV infection associated with an increased risk of extrahepatic cancers?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 11, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

The Great Vaccine Race: Inside the Unprecedented Scramble to Immunize the World Against COVID-19
The cleverest of enemies thrive on surprise attacks. Viruses—and coronaviruses in particular—know this well. Remaining hidden in animal hosts for decades, they mutate steadily, sometimes serendipitously morphing into more effective and efficient infectious agents. When a strain with just the right combination of genetic codes that spell trouble for people makes the leap from animal to human, the ambush begins. Such was the case with SARS-CoV-2, the coronavirus behind COVID-19, and the attack was mostly silent and insidious at first. Many people infected with SARS-CoV-2 remained oblivious as they served as the v...
Source: TIME: Health - September 10, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Magazine Source Type: news

Steatohepatitis Biomarkers and HCC After HCV Elimination Steatohepatitis Biomarkers and HCC After HCV Elimination
This study used steatohepatitis-related biomarkers to evaluate the development of hepatocellular carcinoma by patients with chronic hepatitis C who achieved SVR by DAA treatment.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 9, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

New Approach Allows Safe Transplant of Kidneys Tainted by Hepatitis C
TUESDAY, Sept. 8, 2020 -- New hepatitis C medications are allowing people to receive a kidney transplant from a deceased donor who had the liver disease -- a strategy aimed at getting more lifesaving organs to patients languishing on waitlists. Two... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 8, 2020 Category: General Medicine Source Type: news

New Approach Allows Safe Transplant of Kidneys Tainted by Hepatitis C
Title: New Approach Allows Safe Transplant of Kidneys Tainted by Hepatitis CCategory: Health NewsCreated: 9/8/2020 12:00:00 AMLast Editorial Review: 9/8/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - September 8, 2020 Category: Nutrition Source Type: news

Hepatitis C service specification published
The community pharmacy Hepatitis C Antibody Testing advanced service went live on 1 September 2020. Through this service, people who inject drugs and who are not currently accessing community drug and alcohol treatment services can be tested for the hepatitis C virus at a participating community pharmacy. (Source: NHS Networks)
Source: NHS Networks - September 8, 2020 Category: UK Health Source Type: news

Ascentage Pharma's Bcl-2 Inhibitor APG-2575 Granted Orphan Drug Designation by the FDA for the Treatment of Chronic Lymphocytic Leukemia
SUZHOU, China and ROCKVILLE, Md., Sept. 7, 2020 -- (Healthcare Sales & Marketing Network) -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),... Biopharmaceuticals, Oncology, FDA Ascentage Pharma, APG-2575, chronic lymphocytic leukemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 7, 2020 Category: Pharmaceuticals Source Type: news

Many Advanced Countries Missing Targets for HCV Elimination Many Advanced Countries Missing Targets for HCV Elimination
The World Health Organization wants to eliminate hepatitis C infection by the end of the decade. Researchers performed disease progression models of HCV infection in 45 high-income countries.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 4, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Hepatitis C Treatments Give Patients More Options
Advances in drug treatments approved by the Food and Drug Administration (FDA) are giving the 3.2 million Americans with chronic hepatitis C a chance at a longer, healthier life. That's welcome news for baby boomers, a generation that makes up three of four adults with the hepatitis C virus. (Source: FDA Consumer Health Information Updates)
Source: FDA Consumer Health Information Updates - September 2, 2020 Category: Consumer Health News Authors: FDA Source Type: news

Los tratamientos contra la hepatitis C dan a los pacientes m ás opciones
Los adelantos en los tratamientos con medicamentos aprobados por la Administraci ón de Alimentos y Medicamentos (FDA) están dando a los 3.2 millones de estadounidenses que viven con hepatitis C la oportunidad de vivir una vida más larga y saludable. Los llamados “baby boomers”, la generación cerca a la edad de jubilación y que son tres de cada cuatro portadores del viru s de la hepatitis C, reciben la noticia con júbilo. (Source: FDA Consumer Health Information Updates)
Source: FDA Consumer Health Information Updates - September 2, 2020 Category: Consumer Health News Authors: FDA Source Type: news

One Dose Of Coronavirus Vaccine Likely Won ’ t Be Enough; ‘ We ’ re Looking At Double Shots ’
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p1").init({"mcp":"cbs","width":"100%","height":"100%","video":"4683970","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p1","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 31, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston CNN Coronavirus Coronavirus Vaccine Source Type: news

The Guardian view on African success: a step closer to conquering polio | Editorial
We are tantalisingly close to eradicating the disease. Things may slip backwards because of science, thugs and exponents of ignorancePolio arrives, if it announces itself at all, as a high temperature. Or a sore throat. Maybe a headache, or an upset stomach. It can go within a week or so, and be mistaken for flu. It is transmitted by poor hygiene, largely affects children under five, and many don ’t realise they’ve had it. In 5-10% of cases, however, the virus affects the nerves, paralysing the legs in particular; sometimes it reaches the lungs. For most, this is temporary. For others –30 years ago, this ...
Source: Guardian Unlimited Science - August 30, 2020 Category: Science Authors: Editorial Tags: Polio Vaccines and immunisation Children Pakistan Afghanistan Hepatitis B Taliban Coronavirus outbreak Infectious diseases Health Medical research Science South and Central Asia Society Source Type: news

Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model - Tashkent, Uzbekistan, December 6, 2019-March 15, 2020
This report describes a funding program in Uzbekistan designed to identify and treat cases of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection at a lowered cost with the goal of meeting the World Health Organization's targets to eliminate HBC and HCV infection. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - August 27, 2020 Category: American Health Tags: Hepatitis B Hepatitis C MMWR Morbidity & Mortality Weekly Report Source Type: news

New models help predict liver cancer after successful hepatitis C virus (HCV) treatment
(Spink Health) Digital ILC 2020: European scientists develop new predictive models for HCC in patients with chronic HCV after a sustained virological response to direct-acting antiviral therapy (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 26, 2020 Category: Cancer & Oncology Source Type: news

6th Circuit: OK to ration hepatitis C treatment to prisoners
In a split decision, a panel of the 6th U.S. Circuit Court of Appeals has upheld Tennessee’s rationing of life-saving hepatitis C drugs to prisoners as constitutional (Source: ABC News: Health)
Source: ABC News: Health - August 25, 2020 Category: Consumer Health News Tags: Health Source Type: news

The Role of the Pharmacist in Preventing Hepatitis B in the Context of the Opioid Crisis
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - August 20, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news

Measuring HCV Elimination As a Public Health Threat Measuring HCV Elimination As a Public Health Threat
In this commentary, the authors propose measures to track progress on reducing the global HCV burden, highlighting where the WHO targets may not be achievable, and suggesting practical solutions.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 19, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Namibia: WHO Renew Effort to Address the Hepatitis E Virus Outbreak in Namibia
[WHO] The Namibian government renewed its efforts in containing the Hepatitis E Virus (HEV), which was declared as an outbreak since 14 December 2017. To this end, the "Improving the national preparedness and response capacity to contain infectious disease outbreaks and other drought related public heath events in Namibia" project worth close to four million Namibian dollars was launched by the Embassy of Japan, the World Health Organization (WHO) and the Ministry of Health and Social Services (MoHSS) (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 18, 2020 Category: African Health Source Type: news

Lack of continuous infectious disease pandemic research endangers responses
(American Associates, Ben-Gurion University of the Negev) The coronavirus was also studied considerably less than blood borne viruses like Hepatitis B or C and H.I.V. and its research community has less prolific researchers than the other investigated diseases. This translates into limited collaborations and a non-sustained investment in research on coronaviruses. Such a short-lived investment also reduces funding and may slow down important developments such as new drugs, vaccines or preventive strategies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 17, 2020 Category: International Medicine & Public Health Source Type: news

Busting Up the Infection Cycle of Hepatitis B
(University of Delaware) Researchers at the University of Delaware have gained new understanding of the virus that causes hepatitis B and the " spiky ball " that encloses its genetic blueprint. They looked at how the capsid--a protein shell that protects the blueprint and also drives the delivery of it to infect a host cell--assembles itself. The capsid is an important target in developing drugs to treat hepatitis B, a life-threatening and incurable infection that afflicts more than 250 million people worldwide. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - August 13, 2020 Category: Biology Source Type: news

Hepatitis B: Natural controllers shed light on immunity mechanisms
(Institut Pasteur) To improve our understanding of the antibody response conferring protection against HBV infection, scientists from the Institut Pasteur and Inserm, in collaboration with the Roche Innovation Center in Switzerland, produced and characterized human monoclonal antibodies specific to viral envelope antigens, referred as HBsAg, from blood memory B cells isolated from HBV vaccinees and natural controllers. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - August 13, 2020 Category: Biology Source Type: news

Hepatitis Screening Now for All Patients With Cancer on Therapy Hepatitis Screening Now for All Patients With Cancer on Therapy
All patients with cancer who are candidates for systemic therapy should be screened for hepatitis B, says the American Society of Clinical Oncology.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 5, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

US obesity epidemic could undermine effectiveness of a Covid-19 vaccine
Vaccines protecting against influenza, hepatitis B and rabies are less effective for obese people. As scientists develop a Covid-19 vaccine, experts say obesity could be an impediment, a sobering prospect for the US, where nearly half of all adults are obese. (Source: CNN.com - Health)
Source: CNN.com - Health - August 5, 2020 Category: Consumer Health News Source Type: news

SVR From DAA, Interferon-based Treatments for HCV and HCC Risk SVR From DAA, Interferon-based Treatments for HCV and HCC Risk
How does sustained virologic response from direct-acting antiviral and interferon-based treatments impact the risk of developing hepatocellular carcinoma?Journal of Viral Hepatitis (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - August 5, 2020 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news

First drug for hepatitis D has been approved by european commission
(German Center for Infection Research) The European Commission has approved Hepcludex for the treatment of chronic hepatitis D infection / Successful translation of basic research into clinical applications / entry blocker also demonstrates effectiveness against hepatitis B (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - August 5, 2020 Category: Biology Source Type: news

Routine hepatitis C testing saves long-term expenditure
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - August 1, 2020 Category: Drugs & Pharmacology Source Type: news

Birth dose of hepatitis B vaccine cost effective in Ethiopia
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - August 1, 2020 Category: Drugs & Pharmacology Source Type: news

DAAs for chronic hepatitis  C: good public health investment in Vietnam
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - August 1, 2020 Category: Drugs & Pharmacology Source Type: news

Progress Toward Hepatitis B Control - South-East Asia Region, 2016-2019
This report describes progress of countries in the World Health Organization's South-East Asia region toward reaching 90% hepatitis B vaccination coverage. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - July 30, 2020 Category: American Health Tags: Hepatitis B Hepatitis B Screening Hepatitis B Vaccination MMWR Morbidity & Mortality Weekly Report Source Type: news

Zambia: Zambia Joins the Global Community to Commemorate the World Hepatitis Day
[WHO] To mark the commemoration of the World Hepatitis Day 2020, the World Health Organization has called for a global and united effort to eliminate viral hepatitis as a public health threat by 2030. More than 1.3 million people die annually as a result of Hepatitis B and C. Zambia has therefore joined the global community to commemorate World Hepatitis Day under the theme "Hepatitis free future". The theme highlights the importance of preventing mother-to-child transmission of Hepatitis B and scaling (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 30, 2020 Category: African Health Source Type: news

Nigeria: Over 20 Million Nigerians Infected With Hepatitis - Minister
[Premium Times] About 20 million Nigerian are chronically infected with hepatitis B and C, the minister of health, Osagie Ehanire, said on Tuesday. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 30, 2020 Category: African Health Source Type: news

Nigeria: Hepatitis Day - Medical Groups Screen Children, Call for Government Support
[Premium Times] In commemoration of World Hepatitis Day, a coalition of medical volunteer groups have conducted free hepatitis screening for children and adolescents at Ilaje community, Bariga, Lagos. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 30, 2020 Category: African Health Source Type: news

Nigeria: Why Nigeria Must Find Everyone Who Has Hepatitis and Doesn't Know It
[Premium Times]Kolawole Oluseyi Akande,University of Ibadan (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 28, 2020 Category: African Health Source Type: news

Nigeria: Why We Must Find Everyone Who Has Hepatitis and Doesn't Know It
[The Conversation Africa] World Hepatitis Day - 28 July - is an opportunity to raise awareness of hepatitis and encourage commitments of governments, policy makers and the public towards eradication of this dangerous disease. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 28, 2020 Category: African Health Source Type: news

Pediatric Radiological Case: Autoimmune Hepatitis Pediatric Radiological Case: Autoimmune Hepatitis
Review the imaging studies that led to the diagnosis of autoimmune hepatitis in this 11-year-old who presented with abnormal liver function tests, thrombocytopenia, and hypoalbuminemia.Applied Radiology (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - July 28, 2020 Category: Radiology Tags: Radiology Journal Article Source Type: news

NHS Tayside claims it has 'effectively eliminated' hepatitis C
NHS Tayside targeted injecting drug users in a bid to eradicate the blood borne virus. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - July 28, 2020 Category: Consumer Health News Source Type: news

Spread of hepatitis B in children under five, lowest in decades: WHO
The global prevalence of potentially-deadly hepatitis B in children under age five, dropped to under one per cent in 2019 – down from five per cent in the pre-vaccine decades between the 1980s and early 2000s, the World Health Organization (WHO) reported on Monday. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - July 27, 2020 Category: International Medicine & Public Health Source Type: news

Viral hepatitis: Europe needs to close the testing gap
(European Centre for Disease Prevention and Control (ECDC)) Approximately four in five people living with hepatitis B and three out of four people with hepatitis C infection across the European Union and European Economic Area (EU/EEA) and the UK have not yet been diagnosed. This is a major obstacle on the way towards the Sustainable Development Goal (SDG) for health in 2030 as highlighted by ECDC on occasion of World Hepatitis Day. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 27, 2020 Category: Infectious Diseases Source Type: news

Trial finds drug safe and effective in treating hep-c during pregnancy
(University of Pittsburgh) Critics of the universal hepatitis C screening argue that it's wasteful to test pregnant women for a disease that can't be immediately treated, but results of a small phase I clinical trial suggest otherwise: pregnancy could be an excellent time to diagnose and cure hepatitis C infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 27, 2020 Category: Infectious Diseases Source Type: news

Barriers to Hepatitis C Screening and Linkage to Care Barriers to Hepatitis C Screening and Linkage to Care
This study aimed to identify patient and provider barriers that contribute to suboptimal HCV screening and linkage-to-care. What opportunities exist to improve HCV screening and treatment delivery?Journal of Viral Hepatitis (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 24, 2020 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news

New CDC Guidance for Healthcare Personnel Exposed to HCV New CDC Guidance for Healthcare Personnel Exposed to HCV
New recommendations from the CDC offer guidance for postexposure testing and clinical management of healthcare personnel exposed to hepatitis C virus.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 23, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Recommendations and Reports: Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus - CDC Guidance, United States, 2020
This report describes updated guidance for laboratory testing and follow-up of healthcare personnel who have been potentially exposed to hepatitis C virus as well as recommended treatment of acute hepatitis C virus infection. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - July 23, 2020 Category: American Health Tags: Hepatitis C Infection MMWR Morbidity & Mortality Weekly Report Prevention Infection Control Source Type: news

Closing the gap: finding undiagnosed hepatitis C infections after blood transfusions
(European Centre for Disease Prevention and Control (ECDC)) What is the incidence of viral hepatitis caused by blood transfusions before and after Sweden introduced screening of blood in the early 1990s? In an article published in Eurosurveillance ahead of World Hepatitis Day on 28 July, the authors also try to estimate how many people of those who were infected with hepatitis B and C through blood transfusion still live with undiagnosed hepatitis. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 23, 2020 Category: Infectious Diseases Source Type: news

Hepatitis C drug can help improve condition of coronavirus patients: Study
Though there was no change in recovery time, the researchers also found that the interferon therapy if administered after five days of hospitalisation resulted in increased deaths. (Source: The Economic Times)
Source: The Economic Times - July 23, 2020 Category: Consumer Health News Source Type: news

Routine Hepatitis C Testing at FQHCs Would Be Cost-Effective
WEDNESDAY, July 22, 2020 -- Routine hepatitis C virus (HCV) testing at federally qualified health centers (FQHCs) would be cost-effective and could improve outcomes for people with HCV infections, according to a study published online June 27 in The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 22, 2020 Category: Pharmaceuticals Source Type: news

Ukrainian Men Plead Guilty to Conspiracy and Trafficking of Counterfeit Cancer and Hepatitis Drugs
FDA OCI, guilty, plea, conspiracy, trafficking, counterfeit, cancer drugs, hepatitis drugs, Maksym Nienadov, Healthy Nation, Volodymyr Nikolaienko, misbranded drugs, Keytruda, Abraxane, Epclusa, Maksim Nenadov, undercover purchase, prescription drugs, computer crime, health care fraud, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - July 22, 2020 Category: Medical Law Authors: DOJ Source Type: news

Linkage to and Retention in Care Among Refugees With HBV Linkage to and Retention in Care Among Refugees With HBV
This report assessed a quality improvement intervention and outreach program for refugees with hepatitis B infection at three U.S. refugee screening sites.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 20, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news